![]() ![]() The employee was alleging all manner of wrongdoing. Fuisz had just made contact with a Theranos employee who had just left the company, and the employee was the former lab director. That person, Richard Fuisz, had become suspicious that Theranos was a scam. He wrote a short, skeptical item on his blog and was contacted by someone who had been involved in patent litigation with Elizabeth Holmes. I got a tip from a pathologist in the Midwest who moonlighted as the writer of a blog called “The Pathology Blawg.” He had read a profile of Elizabeth Holmes in The New Yorker and was immediately dubious about the claims she made in that story about her technology’s ability to test tiny blood samples and to run so many tests on tiny blood samples. John Carreyrou: Yes, it was not a primary source. ![]() In this case, your investigation began with a tip from a friend of a friend, correct? Knowledge at Wharton: Journalists often get tips from their sources. Wharton business ethics and legal studies professor Peter Conti-Brown, who teaches about Theranos for the business responsibility core class for Wharton MBAs, also joined the discussion.Īn edited transcript of the conversation follows. He visited the Knowledge at Wharton radio show, which airs on Wharton Business Radio on SiriusXM, to talk about the story. Carreyrou has chronicled the saga in a book titled, Bad Blood: Secrets and Lies in a Silicon Valley Startup. Holmes and former Theranos president Ramesh “Sunny” Balwani have been indicted on federal fraud charges. An investigation by Wall Street Journal reporter John Carr eyrou uncovered the truth that led to the company’s downfall. Holmes, a striking blonde with a bold presence, racked up big-name investors, forged a partnership with Walgreens and raked in the money: Theranos reached a valuation of $9 billion.īut this story of a Silicon Valley unicorn was too good to be true. In 2003, the 19-year-old college dropout founded Theranos, a medical technology company that promised to revolutionize health care with a device that could test for a range of conditions using just a few drops of blood from a finger prick. Reporter John Carreyrou talks with and Wharton's Peter Conti-Brown about the downfall of Theranos.Įlizabeth Holmes had the world on a string. The Meeting Style That Generates Breakthrough Solutions August 7, 2023.Strengthen Your Leadership with the Science of Awe August 21, 2023.Timing Matters: Design the Day for Maximum Productivity October 20, 2023.The Power of Intentional Networking November 20, 2023.Meet the Authors: Wharton’s Katy Milkman on How to Change May 14, 2021.Meet the Authors: Mauro Guillén on How Businesses Succeed in a Global Marketplace June 21, 2021.Meet the Authors: Wharton’s Peter Cappelli on The Future of the Office November 4, 2021.Meet the Authors: Erika James and Lynn Perry Wooten on The Prepared Leader October 3, 2022.Improving Accessibility in the Workplace - and in Space May 16, 2023.How Employers Can Support Women’s Reproductive Rights June 20, 2023.How to Use AI in a Fair and Responsible Way November 9, 2023.Diversity Is Critical for the Future of AI November 10, 2023.Great Question: Kevin Werbach on Cryptocurrency and Fintech July 21, 2021.Great Question: Dean Erika James on Crisis Management August 16, 2021.Great Question: Wendy De La Rosa on Personal Finance October 15, 2021.Great Question: Witold Henisz on ESG Initiatives November 17, 2021.Making the Business Case for ESG May 3, 2022.How Companies and Capital Can Be Forces for Good June 21, 2022.Investing in Refugee Entrepreneurs in East Africa August 8, 2022.Why Employee-owned Companies Are Better at Building Worker Wealth November 11, 2022.How Can AI and the Human Brain Work Together? November 9, 2023.Can AI Make You a Better Manager? November 9, 2023.What Role Can AI Play in Sports? November 9, 2023.What Is the Future of AI? November 9, 2023. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |